EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer

Shijuan Lin, Lily L Nguyen, Alexandra McMellen, Michael S Leibowitz, Natalie Davidson, Daniel Spinosa, Benjamin G Bitler iD

Molecular Diagnosis & Therapy · 2025

DOI: 10.1007/s40291-024-00757-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Diagnosis & Therapy, 2025. Verfasst von Shijuan Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, 12700 East 19th …. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Metabolomics, Proteomics, Genomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Defense, NCI NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To better understand ovarian cancer lethality and treatment resistance, sophisticated computational approaches are required that address the complexity of the tumor microenvironment, genomic heterogeneity, and tumor evolution. The ovarian cancer tumor ecosystem consists of multiple tumors and cell types that support disease growth and progression. Over the last two decades, there has been a revolution in -omic methodologies to broadly define components and essential processes within the tumor microenvironment, including transcriptomics, metabolomics, proteomics, genome sequencing, and single-cell analyses. While most of these technologies comprehensively characterize a single biological process, there is a need to understand the biological and clinical impact of integrating multiple -omics platforms. Overall, multi-omics is an intriguing analytic framework that can better approximate biological complexity; however, data aggregation and integration pipelines are not yet sufficient to reliably glean insights that affect clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsMetabolomicsProteomicsGenomicsHumansFemaleTumor MicroenvironmentSingle-Cell AnalysisComputational BiologyBiomarkers, TumorTranscriptomeMultiomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Divisions of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, 12700 East 19th Avenue, MS 8613, Aurora, CO, 80045, USA.
  • Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, USA.
  • Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
  • Divisions of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, 12700 East 19th Avenue, MS 8613, Aurora, CO, 80045, USA. Benjamin.Bitler@cuanschutz.ed…

ORCID-Profile: Benjamin G Bitler

Förderung

  • Department of Defense
  • NCI NIH HHS
  • NHGRI NIH HHS
  • CSR NIH HHS
  • NIAID NIH HHS
  • Center for Scientific Review

Zitieren

APA

Lin, S., Nguyen, L. L., McMellen, A., Leibowitz, M. S., Davidson, N., Spinosa, D., & Bitler, B. G. (2025). Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-024-00757-3

Vancouver

Lin S, Nguyen LL, McMellen A, Leibowitz MS, Davidson N, Spinosa D, et al. Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer. Molecular Diagnosis & Therapy. 2025. doi:10.1007/s40291-024-00757-3

BibTeX
@article{Lin2025,
  author = {Lin, Shijuan and Nguyen, Lily L and McMellen, Alexandra and Leibowitz, Michael S and Davidson, Natalie and Spinosa, Daniel and Bitler, Benjamin G},
  title = {Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer},
  journal = {Molecular Diagnosis & Therapy},
  year = {2025},
  doi = {10.1007/s40291-024-00757-3}
}
Kostenlos starten →